In terms of molecular function (Figure 3(d)), vitamin C used to treat HIE mainly involves the regulation of nuclear hormone receptor binding, hormone receptor binding, RNA polymerase II inhibits transcription factor binding, nuclear receptor binding, ligand-activated transcription factor activity, ubiquitin-like protein ligase binding, p53 binding, and regulatory transcription factor binding. Here, TP53 is linked to perinatal asphyxia.